
Pioneering mRNA technology - Moderna
Moderna develops mRNA therapeutics and vaccines with broad tissue delivery but lacks Kernal’s AI-driven selective translation for precise T-cell CAR programming. Its platform excels in rapid manufacturing and approved products yet focuses less on in vivo cell engineering for cancer or autoimmunity. Pricing is commercial for vaccines; Kernal remains pre-commercial with targeted oncology focus.
Moderna is pioneering mRNA technology to deliver the greatest possible impact to people through mRNA medicines. The company has 45 development programs and 36 ongoing clinical trials, with a platform that enables rapid design, research and testing of multiple mRNAs within days. mRNA medicines contain no animal products or preservatives and fight diseases by prompting the immune system to create tools to treat or prevent disease.
Free

Culturally responsive mental health resources and therapist directory for Black women and girls.

NYC-based online therapy with licensed therapists accepting insurance for anxiety, trauma, and life transitions.
Online therapy for teens and parents via text, phone, and video from licensed therapists.